Hemophagocytic syndrome associated with rheumatoid arthritis

Internal Medicine

Volumn 46, Issue 21, 2007, Pages 1809-1813

  Katoh, Nagaaki ^a   Gono, Takahisa ^a   Mitsuhashi, Shigeaki ^a   Fukushima, Kazuhiro ^a   Takei, Yo Ichi ^a   Matsuda, Masayuki ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bucillamine; Corticosteroid; Cyclosporine A; Disseminated intravascular coagulation; Hemophagocytic syndrome; Rheumatoid arthritis

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN III; BUCILLAMINE; CYCLOSPORIN A; FIBRIN DEGRADATION PRODUCT; GABEXATE MESILATE; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CELL INFILTRATION; COMBINATION CHEMOTHERAPY; DISEASE ACTIVITY; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG WITHDRAWAL; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MACROPHAGE; MONOTHERAPY; PANCYTOPENIA; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYSTEINE; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED;

EID: 36249007510     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0396     Document Type: Article

References (25)

1. Kumakura S, Ishikura H, Endo J, Kobayashi S. Autoimmune-associated hemophagocytosis. Am J Hematol 50: 148-149, 1995.
2. Yamanouchi J, Yamauchi Y, Yokota E, Matsumoto I. Hemophagocytic syndrome in a patient with rheumatoid arthritis. Ryumachi 38: 731-734, 1998 (in Japanese with English abstract).
3. Sandhu C, Chesney A, Piliotis E, Buckstein R, Koren S. Macrophage activation syndrome after etanercept treatment. J Rheumatol 34: 241-242, 2007.
4. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 14: 205-215, 2004.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
6. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659-662, 1949.
7. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35: 498-502, 1992.
8. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66: 135-151, 1997.
9. Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 65: 215-226, 1997.
10. Farquhar JW, Claireaux AF. Familial hemophagocytic reticulosis. Arch Dis Child 27: 519-525, 1952.
11. Kumakura S, Kondo M, Tsumura H, Murakawa Y, Ishikura H, Kobayashi S. Hemophagocytic syndrome. Nihon Rinsho Men'eki Gakkai Kaishi 23: 670-673, 2000 (in Japanese).
12. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993-1002, 1979.
13. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 114: 387-390, 1991.
14. Onishi R, Namiuchi S. Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med 33: 607-611, 1994.
15. Hashimoto N, Nishii N, Hashimoto M, et al. Two cases of hemophaogocytic syndrome. Onomichishibyoishi 13: 123-126, 1998 (in Japanese).
16. Shibilia J, Javier RM, Albert A, Cazenave JP, Kuntz JL. Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. J Rheumatol 25: 1218-1220, 1998.
17. Kuyama J, Nakao H, Take H, et al. Cytomegalovirus-associated hemophagocytic syndrome and multiple intestinal ulcers with perforation in a patient with rheumatoid arthritis. Shiritsutoyonakabyouin Igakuzasshi 1: 53-58, 2000 (in Japanese).
18. Sekiuchi M, Nakabayashi K, Marumo T, Arimura Y, Yamada A. Hemophagocytic syndrome associated with hypercytokinemia in a patient with rheumatoid arthritis. Ryumachi 43: 696-702, 2003 (in Japanese with English abstract).
19. Niang A, Diallo S, Ka MM, et al. Hemophagocytic syndrome complicating adult's seropositive rheumatoid arthritis. Rev Med Interne 25: 826-828, 2004 [abstract].
20. Gutierrez-Rave Pecero VM, Luque Marquez R, Ayerza Lerthundi MA, Fernandez Jurado A. Phenytoin-induced hemocytophagic histiocytosis indistinguishable from malignant histiocytosis. South Med J 84: 649-650, 1991.
21. Yang YC, Jou ST, Chang YH, Liang JS, Lee WT. Hemophagocytic syndrome associated with antiepileptic drug. Pediatr Neurol 30: 358-360, 2004.
22. Lambotte O, Costedoat-Chalumeau N, Amoura Z, Piette JC, Cacoub P. Drug-induced hemophagocytosis. Am J Med 112: 592-593, 2002.
23. Jain D, Dash S. Pancytopenia due to extensive hemophagocytosis following anti-tubercular treatment. Am J Hematol 75: 118-119, 2004.
24. Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 28: 865-867, 2001.
25. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of Etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 30: 401-403, 2003.